Blood PressureHypertensionAdrenergic beta-AntagonistsAntihypertensive AgentsBlood Pressure DeterminationPressureBlood Pressure Monitoring, AmbulatoryHeart RateRats, Inbred SHRMetoprololAngiotensin-Converting Enzyme InhibitorsDiureticsHypotensionCalcium Channel BlockersAtenololPropanolaminesReninBisoprololSystoleCeliprololDiet, Sodium-RestrictedHemodynamicsTime FactorsSodium Chloride Symporter InhibitorsDouble-Blind MethodHydrochlorothiazideCultured Milk ProductsRats, Inbred WKYDiastoleKidneySodium, DietarySodium Chloride, DietaryVascular ResistanceDose-Response Relationship, DrugCarteololIndapamideBody WeightHospital PlanningRisk FactorsHydrostatic PressureCardiovascular DiseasesAngiotensin IITreatment OutcomeProspective StudiesCross-Over StudiesBetaxololHypertension, RenalTelemetryCaptoprilRenin-Angiotensin SystemBlood GlucoseRats, Sprague-DawleyDrug Therapy, CombinationHydralazineAldosteroneBlood Pressure MonitorsDesoxycorticosteroneVasodilationSodiumAortaHypertension, RenovascularPropranololTimololTetrazolesFollow-Up StudiesSodium ChlorideBaroreflexCarbazolesNorepinephrineInterleukin-1betaAngiotensin II Type 1 Receptor BlockersClinical Trials as TopicVasodilator AgentsLosartanPotassiumRandom AllocationVasoconstrictionVasoconstrictor AgentsRandomized Controlled Trials as TopicLabetalolDisease Models, AnimalObesityHeart FailureCohort StudiesAcebutololAnalysis of VarianceRats, WistarIntracranial PressureNitric OxideLipidsArterial PressureIntraocular PressurePulseSympathetic Nervous SystemMesenteric ArteriesTransducers, PressureKidney DiseasesCross-Sectional Studiesbeta 2-MicroglobulinInsulin